Search

everythinglearnresearchcommunity

for

Search:↓

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Three to five ovarian punctures are best for improving fertility in women with PCOS without harming the ovaries.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Metformin and clomiphene citrate together improve pregnancy chances and reduce miscarriages in women with PCOS.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

The 18-year-old girl likely has a condition called müllerian agenesis, which caused her to not have a uterus and experience no menstrual periods.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

High MUC-18/MCAM levels in blood indicate a worse outlook for melanoma patients.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

The new topical growth hormone formula has high skin penetration and bioavailability.

Increasing the levels of a protein called FGF9 can promote hair growth, but humans may not respond the same way due to a lack of certain cells.

3α-androstanediol helps reduce age-related cognitive and mood declines in male rats, unlike testosterone.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.

Testosterone pellets may help women's sexual function but have safety concerns and need more research.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Hair relaxers are linked to reduced cystine levels and potential hair damage.